Call Options Transactions Made in Q2 2023 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q2 2023. The information is specifically focused on institutions that hold call options of Keros Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-400- 40.0% |
$14.9K - $20.4K
|
600
$7.1K
|